| 000 | 01814 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513235644.0 | ||
| 264 | 0 | _c20010517 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.2001.4756 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaschott, T | |
| 245 | 0 | 0 |
_a1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cApr 2001 |
||
| 300 |
_a80-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aButyrates _xpharmacology |
| 650 | 0 | 4 |
_aCaco-2 Cells _xcytology |
| 650 | 0 | 4 |
_aCalcitriol _xpharmacology |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p27 |
| 650 | 0 | 4 |
_aCyclins _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Calcitriol _xbiosynthesis |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTriglycerides _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aTumor Suppressor Proteins |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aWächtershäuser, A | |
| 700 | 1 | _aSteinhilber, D | |
| 700 | 1 | _aStein, J | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 283 _gno. 1 _gp. 80-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2001.4756 _zAvailable from publisher's website |
| 999 |
_c11256843 _d11256843 |
||